Navigation Links
Thyroid Treatment Guidelines for Pregnant Women Revised
Date:8/14/2012

TUESDAY, Aug. 14 (HealthDay News) -- Thyroid hormone is critical for normal fetal brain development, and hormonal problems among pregnant women must be properly managed, according to the Endocrine Society, which just revised its guidelines on treating thyroid-related medical issues before, during and after pregnancy.

Too much or not enough thyroid hormone can harm both women and their unborn babies, the experts said. The treatment guidelines update the 2007 version.

"Pregnancy may affect the course of thyroid diseases and, conversely, thyroid diseases may affect the course of pregnancy," said lead study author Dr. Leslie de Groot, a research professor at the University of Rhode Island, in a society news release. "Pregnant women may be under the care of multiple health care professionals, including obstetricians, nurse midwives, family practitioners and endocrinologists, making the development of guidelines all the more critical."

Women who are hypothyroid (their thyroid function is underactive) are at greater risk for infertility and are more likely to have anemia, gestational hypertension and postpartum hemorrhage, the news release noted. If not treated, hypothyroidism during pregnancy can lead to premature birth, low birth weight and respiratory distress among newborns. Overactive thyroid function, or hyperthyroidism, also can lead to miscarriage.

The Endocrine Society made the following revisions to its clinical practice guidelines:

  • Doctors should interpret serum-free thyroxine levels cautiously during pregnancy. The experts advised that using trimester-specific reference ranges would improve the interpretation of pregnant women's thyroid-function tests.
  • The drug propylthiouracil (PTU) should be the primary treatment for hyperthyroidism during the first trimester of pregnancy. The experts cautioned the alternate treatment -- methimazole -- may increase the risk for birth defects. Methimazole, however, can be used if PTU is unavailable or if women have a negative reaction to the drug. Because PTU may be harmful to the liver in rare cases, once women complete their first trimester, they should switch from PTU to methimazole.
  • Women who are breast-feeding should take 250 micrograms of iodine daily to ensure their infants are getting 100 micrograms of iodine each day.
  • Daily prenatal vitamins should contain 150 to 200 micrograms of iodine to protect women from iodine deficiency.
  • Women with Graves' disease, a history of Graves' disease, a previous newborn with Graves' disease or previously elevated thyroid stimulating hormone antibodies should have these antibodies measured before they are 22 weeks pregnant. These antibodies cross the placenta and can stimulate or restrict the fetal thyroid, the experts explained.
  • The fetuses of women who have thyroid stimulating hormone receptor antibodies at least two to three time higher than normal or who are treated with anti-thyroid drugs should be screened for thyroid problems. This can be done during the fetal ultrasound women routinely undergo when they are between 18 and 22 weeks pregnant. An enlarged thyroid, growth restriction, severe swelling, presence of goiter, advanced bone age or heart failure could be signs of thyroid problems in a fetus.
  • Fine-needle aspiration should be considered for women with nodules 5 millimeters to 1 centimeter in size who have a high-risk history or suspicious findings on an ultrasound. Women with complex nodules 1.5 centimeters to 2 centimeters also should undergo this procedure. The guidelines note that this can be delayed until after delivery for women who are at least 34 weeks pregnant.

The news release noted that consensus was not reached on whether all newly pregnant women should be screened for thyroid problems, but added that some experts support universal screening for thyroid problems by the time women are nine weeks pregnant.

The revised guidelines appear in the August issue of the Journal of Clinical Endocrinology and Metabolism.

More information

The U.S. Department of Health and Human Services has more about pregnancy and thyroid disease.

-- Mary Elizabeth Dallas

SOURCE: The Endocrine Society, news release, Aug. 10, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Drug May Aid People With Advanced Thyroid Cancer
2. Experts issue recommendations for treating thyroid dysfunction during and after pregnancy
3. Detecting thyroid disease by computer
4. Gene expression test identifies low-risk thyroid nodules
5. Hyperthyroidism linked to increased risk of hospitalization for heart and blood-vessel disease
6. Mayo Clinic: Molecule thought cancer foe actually helps thyroid tumors grow
7. Obese More Likely to Be Diagnosed With Advanced Thyroid Cancer
8. Staging and risk stratification of thyroid cancer improved with SPECT/CT
9. Lower-Dose Radioiodine Effective Against Thyroid Cancer
10. Thyroid Condition Linked to Heart Problems: Study
11. Scientists decode TREX which could see new treatments for cancer realized
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Thyroid Treatment Guidelines for Pregnant Women Revised
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... 2017 Solentim, the developer of instrumentation ... of a major new product line called the ... VIPS has been developed for automatically seeding single ... part of the process to generate clonally-derived cell ... more reliable solution when compared to traditional single ...
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: